Daniela Berger

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Engraftment in NSGSCF mice correlates with the WHO category and prognosis in systemic mastocytosis.

Engraftment in NSGSCF mice correlates with the WHO category and prognosis in systemic mastocytosis.

Journal: Leukemia

Published: December 30, 2022

BRD4 degradation blocks expression of MYC and multiple forms of stem cell resistance in Ph+ chronic myeloid leukemia.

BRD4 degradation blocks expression of MYC and multiple forms of stem cell resistance in Ph+ chronic myeloid leukemia.

Journal: American journal of hematology

Published: March 08, 2022

Expression and regulation of Siglec-6 (CD327) on human mast cells and basophils.

Expression and regulation of Siglec-6 (CD327) on human mast cells and basophils.

Journal: The Journal of allergy and clinical immunology

Published: February 15, 2022

CDK4/CDK6 Inhibitors Synergize with Midostaurin, Avapritinib, and Nintedanib in Inducing Growth Inhibition in KIT D816V+ Neoplastic Mast Cells.

CDK4/CDK6 Inhibitors Synergize with Midostaurin, Avapritinib, and Nintedanib in Inducing Growth Inhibition in KIT D816V+ Neoplastic Mast Cells.

Journal: Cancers

Published: December 31, 2021

Secondary basophilic leukemia in Ph-negative myeloid neoplasms: A distinct subset with poor prognosis.

Secondary basophilic leukemia in Ph-negative myeloid neoplasms: A distinct subset with poor prognosis.

Journal: Neoplasia (New York, N.Y.)

Published: June 25, 2021

Asciminib and ponatinib exert synergistic anti-neoplastic effects on CML cells expressing BCR-ABL1 T315I-compound mutations.

Asciminib and ponatinib exert synergistic anti-neoplastic effects on CML cells expressing BCR-ABL1 T315I-compound mutations.

Journal: American journal of cancer research

Published: March 30, 2021

Culturing cells with mast cell phenotype and function: Comparison of peripheral blood and bone marrow as a source.

Culturing cells with mast cell phenotype and function: Comparison of peripheral blood and bone marrow as a source.

Journal: Journal of immunological methods

Published: February 12, 2021

Phenotypic characterization of leukemia-initiating stem cells in chronic myelomonocytic leukemia.

Phenotypic characterization of leukemia-initiating stem cells in chronic myelomonocytic leukemia.

Journal: Leukemia

Published: November 13, 2020

STAT5 is Expressed in CD34+/CD38- Stem Cells and Serves as a Potential Molecular Target in Ph-Negative Myeloproliferative Neoplasms.

STAT5 is Expressed in CD34+/CD38- Stem Cells and Serves as a Potential Molecular Target in Ph-Negative Myeloproliferative Neoplasms.

Journal: Cancers

Published: April 03, 2020

CDK4/CDK6 inhibition as a novel strategy to suppress the growth and survival of BCR-ABL1T315I+ clones in TKI-resistant CML.

CDK4/CDK6 inhibition as a novel strategy to suppress the growth and survival of BCR-ABL1T315I+ clones in TKI-resistant CML.

Journal: EBioMedicine

Published: August 08, 2019

A kinase profile-adapted drug combination elicits synergistic cooperative effects on leukemic cells carrying BCR-ABL1T315I in Ph+ CML.

A kinase profile-adapted drug combination elicits synergistic cooperative effects on leukemic cells carrying BCR-ABL1T315I in Ph+ CML.

Journal: Leukemia research

Published: October 08, 2018

Identification of a leukemia-initiating stem cell in human mast cell leukemia.

Identification of a leukemia-initiating stem cell in human mast cell leukemia.

Journal: Leukemia

Published: September 25, 2018

Showing 1-12 of 21

Last Updated: 09/26/2026